Lombard Odier Asset Management (Usa) Corp Repligen Corp Transaction History

Lombard Odier Asset Management (Usa) Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 13, 2018	SELL	$32.53 - $38.92 $3.25 Million - $3.89 Million	-100,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $3.7 Million - $4.61 Million	100,000	100,000 $3.83 Million

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.78B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.